1. Home
  2. FOLD vs VC Comparison

FOLD vs VC Comparison

Compare FOLD & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • VC
  • Stock Information
  • Founded
  • FOLD 2002
  • VC 2000
  • Country
  • FOLD United States
  • VC United States
  • Employees
  • FOLD N/A
  • VC N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • VC Auto Parts:O.E.M.
  • Sector
  • FOLD Health Care
  • VC Consumer Discretionary
  • Exchange
  • FOLD Nasdaq
  • VC Nasdaq
  • Market Cap
  • FOLD 2.9B
  • VC 2.3B
  • IPO Year
  • FOLD 2007
  • VC 2000
  • Fundamental
  • Price
  • FOLD $8.43
  • VC $78.35
  • Analyst Decision
  • FOLD Strong Buy
  • VC Buy
  • Analyst Count
  • FOLD 9
  • VC 13
  • Target Price
  • FOLD $17.00
  • VC $119.92
  • AVG Volume (30 Days)
  • FOLD 2.6M
  • VC 378.4K
  • Earning Date
  • FOLD 05-08-2025
  • VC 04-24-2025
  • Dividend Yield
  • FOLD N/A
  • VC N/A
  • EPS Growth
  • FOLD N/A
  • VC N/A
  • EPS
  • FOLD N/A
  • VC 9.82
  • Revenue
  • FOLD $528,294,999.00
  • VC $3,866,000,000.00
  • Revenue This Year
  • FOLD $21.91
  • VC N/A
  • Revenue Next Year
  • FOLD $22.22
  • VC $4.40
  • P/E Ratio
  • FOLD N/A
  • VC $7.98
  • Revenue Growth
  • FOLD 32.29
  • VC N/A
  • 52 Week Low
  • FOLD $8.36
  • VC $75.75
  • 52 Week High
  • FOLD $12.65
  • VC $119.16
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 35.37
  • VC 38.19
  • Support Level
  • FOLD $8.40
  • VC $79.45
  • Resistance Level
  • FOLD $9.26
  • VC $84.42
  • Average True Range (ATR)
  • FOLD 0.25
  • VC 2.63
  • MACD
  • FOLD -0.04
  • VC -0.26
  • Stochastic Oscillator
  • FOLD 7.78
  • VC 9.07

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

Share on Social Networks: